Australia Black Cumin Seed Oil Market Size, Share & Report 2026-2034

Market Overview

The Australia black cumin seed oil market is witnessing strong growth as rising consumer interest in natural health products, scientific validation of Nigella sativa's therapeutic properties, and expanding complementary medicine adoption are driving demand across the country. The market size was valued at USD 538.77 Million in 2025 and is projected to reach USD 1,072.43 Million by 2034, exhibiting a compound annual growth rate (CAGR) of 7.95% during 2026-2034. This growth is being supported by Australia's complementary medicines industry reaching AUD 6.3 billion in 2025, with 74% of Australians using complementary medicines according to Complementary Medicines Australia (CMA), and the expanding multi-channel retail infrastructure including the AUD 8.8 billion Chemist Warehouse-Sigma Healthcare merged entity.

Request for a Sample Report: https://www.imarcgroup.com/australia-black-cumin-seed-oil-market/requestsample

Porter's Five Forces Analysis – Australia Black Cumin Seed Oil Market

The Australia black cumin seed oil market, valued at USD 538.77 Million in 2025 and projected to reach USD 1,072.43 Million by 2034 at a CAGR of 7.95%, reflects a structurally attractive and science-backed industry environment with strong growth fundamentals driven by increasing health consciousness, regulatory trust frameworks, and expanding retail distribution channels.

Bargaining Power of Suppliers – Moderate (Import-Dependent but Diversified)

•      Australia relies on imported Nigella sativa seeds primarily from India, Turkey, Egypt, and Middle Eastern countries, with leading domestic brands such as Hab Shifa sourcing organically grown, non-irradiated seeds from India, while multiple origin countries provide diversified procurement options for processors.

•      Australia's organic food market reached USD 1.1 billion in 2024 and is projected to reach USD 2.2 billion by 2033 at a 7.49% CAGR, with over 53 million hectares under certified organic management, establishing rigorous quality standards through ACO and NASAA certification bodies that suppliers must comply with.

•      Research published in 2024 in the International Journal of Molecular Sciences confirmed that seed origin significantly impacts thymoquinone content and therapeutic potency, with premium brands reporting volatile oil content up to 6.3% compared to an industry norm of 0.3-1.5%, making supplier quality selection a critical competitive factor.

Bargaining Power of Buyers – Moderate to High (Health-Conscious and Informed)

•      Approximately 74% of Australians use complementary medicines according to CMA's 2025 Industry Snapshot, with the complementary medicines industry reaching AUD 6.3 billion in annual revenue and projected to grow at 5.7% CAGR over the next five years, indicating a large and engaged buyer base.

•      The Chemist Warehouse-Sigma Healthcare merger in early 2025 created an AUD 8.8 billion pharmacy retail giant with over 1,800 stores, while the Australia ePharmacy market is projected to grow from USD 3,609.64 million in 2024 to USD 9,228.69 million by 2032, expanding omnichannel buyer access.

•      TGA-listed status for black seed oil products serves as a critical trust signal for Australian buyers, with the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2026 updated as of March 2026, ensuring transparent quality standards that empower informed consumer purchasing decisions.

Threat of New Entrants – Low to Moderate (Regulated Quality Environment)

•      All complementary medicines sold in Australia must be listed or registered on the Australian Register of Therapeutic Goods (ARTG), with the TGA releasing updated guidance in November 2024 on data requirements for active ingredients, creating a structured regulatory pathway that ensures product quality and consumer safety.

•      FSANZ conducts thorough risk assessments for food products and approved 20 applications in 2024-25, with the Food Standards Code updated in March 2025, establishing clear compliance requirements for new entrants marketing black cumin seed oil as a food ingredient.

•      Cold-press oil extraction achieves only 80-85% efficiency compared to heat-based methods, requiring additional filtration steps and higher capital investment, while the premium cold-press segment is growing above-average rates fueled by consumer demand for minimally processed wellness products.

Threat of Substitutes – Low to Moderate (Unique Bioactive Profile)

•      The Australia fish oil market is expected to reach USD 233.3 million by 2035, with established brands including Blackmores, Swisse Wellness, and Nature's Way dominating the omega-3 supplement space, while hemp seed oil is projected to grow globally from USD 147.8 million to USD 855.7 million by 2035, representing active but complementary substitute categories.

•      A comprehensive 2024 review in the International Journal of Molecular Sciences confirmed that thymoquinone, the primary bioactive compound in black cumin seed oil, possesses unique multi-target anti-inflammatory, antioxidant, antimicrobial, and hypoglycemic properties that no single substitute oil replicates, supporting strong product differentiation.

•      Biomedical research publications mentioning Nigella sativa grew from 277 annually in 2015 to 1,265 in 2025, with 51 clinical trials identified on ClinicalTrials.gov as of October 2024, reflecting accelerating scientific validation that strengthens consumer preference for black seed oil over alternative wellness oils.

Competitive Rivalry – Moderate (Fragmented with Brand Leaders)

•      Hab Shifa, established in 2010, leads as Australia's most recognized domestic black seed oil brand, offering ACO-certified organic and TGA-listed products sourced from India, with distribution across health food stores, pharmacies, and Amazon.com.au, setting quality benchmarks for the market.

•      The competitive landscape includes international brands such as The Blessed Seed and Amazing Herbs alongside Australian niche players including Black Seed Oils Australia, Halkab, and Escentials of Australia, creating a fragmented market differentiated by seed origin, organic certification, and thymoquinone concentration.

•      The broader Australia dietary supplements market reached USD 3.9 billion in 2025 and is projected to reach USD 7.2 billion by 2034, with growing demand for plant-based, clean-label, and personalized supplements intensifying competitive innovation across all wellness product categories.

Market Trends

Scientific Validation Driving Mainstream Consumer Adoption

The growing body of clinical research is positioning black cumin seed oil as a scientifically credible wellness product in the Australian market. Biomedical research publications mentioning Nigella sativa increased from 277 annually in 2015 to 1,265 in 2025, while 51 clinical trials have been registered on ClinicalTrials.gov. A 2025 peer-reviewed study published in Food Science and Nutrition confirmed black cumin seed's anti-adipogenic effects and lipid-lowering properties in human subjects, further strengthening evidence-based consumer demand and supporting premium product positioning across pharmacy and health food retail channels.

Multi-Channel Retail Expansion Broadening Market Access

The convergence of pharmacy consolidation and e-commerce growth is expanding distribution channels for black cumin seed oil products across Australia. The Chemist Warehouse-Sigma Healthcare merger creating an AUD 8.8 billion retail network with over 1,800 stores, combined with the ePharmacy market projected to reach USD 9.2 billion by 2032, is enabling both established brands and new entrants to reach health-conscious consumers through integrated physical and digital channels. CMA reports that the mood and relaxation supplement segment showed the most dynamic growth at 20.6% CAGR between 2019-2024, indicating broader wellness category momentum.

Market Summary

•      The Australia black cumin seed oil market is projected to grow from USD 538.77 Million in 2025 to USD 1,072.43 Million by 2034 at a 7.95% CAGR, driven by accelerating scientific validation, rising health consciousness, and expanding complementary medicine adoption among 74% of Australians.

•      Thymoquinone, the primary bioactive compound in Nigella sativa, possesses unique multi-target therapeutic properties confirmed by 1,265 annual research publications and 51 registered clinical trials, establishing strong product differentiation from competing wellness oils.

•      The complementary medicines industry reached AUD 6.3 billion in 2025 with 5.7% projected annual growth, while TGA regulatory frameworks and organic certifications from ACO and NASAA ensure quality standards that build consumer trust and market credibility.

•      Multi-channel retail expansion through the AUD 8.8 billion Chemist Warehouse-Sigma merged entity with 1,800+ stores and the rapidly growing ePharmacy market is broadening distribution access for black cumin seed oil products across Australia.

•      Cold-press extraction technology and organic certification requirements are driving premiumization in the market, with brands differentiating through seed origin quality, thymoquinone concentration standardization, and TGA-listed product status.

Market Growth Drivers

Rising Health Consciousness and Complementary Medicine Adoption

Australia's robust complementary medicines culture is creating sustained demand for black cumin seed oil products. With 74% of Australians using complementary medicines and the industry reaching AUD 6.3 billion in 2025, consumer openness to natural health solutions is at historically high levels. The dietary supplements market projected to reach USD 7.2 billion by 2034, combined with growing consumer preference for plant-based, clean-label products, is positioning black cumin seed oil as a premium wellness ingredient with strong appeal across demographic segments.

Expanding Scientific Evidence Base and Regulatory Trust

The accelerating pace of clinical research on Nigella sativa is strengthening the scientific credibility of black cumin seed oil products in Australia. With research publications growing from 277 annually in 2015 to 1,265 in 2025 and 51 clinical trials identified on ClinicalTrials.gov, evidence for thymoquinone's anti-inflammatory, antioxidant, and metabolic benefits is continuously expanding. The TGA's updated Permissible Ingredients Determination in March 2026 and FSANZ's rigorous food standards framework provide regulatory trust that encourages both consumer confidence and industry investment.

Market Segments

By Product Type

•      Cold-Pressed Oil

•      CO2 Extracted Oil

•      Solvent Extracted Oil

•      Others

By Form

•      Liquid Oil

•      Capsules/Softgels

•      Powder

•      Others

By Application

•      Dietary Supplements and Nutraceuticals

•      Food and Beverage

•      Personal Care and Cosmetics

•      Pharmaceuticals

•      Others

By Distribution Channel

•      Pharmacies and Drug Stores

•      Health Food Stores

•      Supermarkets and Hypermarkets

•      Online Retail

•      Others

By Region

•      New South Wales

•      Victoria

•      Queensland

•      Western Australia

•      South Australia

•      Others

Competitive Landscape

The Australia black cumin seed oil market features a competitive landscape comprising established domestic brands and international wellness companies. Key players operating in the market include Hab Shifa, The Blessed Seed, Amazing Herbs, Black Seed Oils Australia, Halkab, Escentials of Australia, Range Products Australia, and Mindful Foods. These companies are differentiating through organic certification (ACO, NASAA), TGA-listed product status, seed origin transparency, and thymoquinone concentration standardization. The market is witnessing increasing product innovation across liquid oils, capsules, and topical formulations, with brands expanding distribution through pharmacies, health food stores, and rapidly growing e-commerce channels.

Latest Recent News & Development

May 2026: NutraIngredients published a comprehensive feature on the legacy and promise of black seed oil, reporting that biomedical research publications on Nigella sativa grew from 277 annually in 2015 to 1,265 in 2025, reflecting accelerating scientific interest.

March 2026: The TGA updated the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2026, commencing on 1 March 2026, updating listed medicine ingredient requirements applicable to black cumin seed oil supplements.

Early 2025: The Chemist Warehouse-Sigma Healthcare merger was finalized, creating an AUD 8.8 billion pharmacy retail giant with over 1,800 stores, reshaping the retail distribution landscape for health supplements including black seed oil products.

2025: Complementary Medicines Australia launched its 2025 Industry Snapshot reporting the industry reached AUD 6.3 billion in annual revenue, with 74% of Australians using complementary medicines.

December 2024: A comprehensive review published in the International Journal of Molecular Sciences covered Nigella sativa's pharmacological properties and clinical applications, identifying 51 clinical trials.

Browse Full Report with TOC & List of Figures: https://www.imarcgroup.com/australia-black-cumin-seed-oil-market/toc

About Us

IMARC Group is a global management consulting firm that helps companies in making business strategies. We have been serving the market research industry for over a decade, and have a strong client base of over 5,000+ companies across various industries. Our market research reports cover over 3,000+ markets, and we offer a wide range of services, including market research, competitive intelligence, and business strategy consulting. Our reports are based on a combination of primary and secondary research, and we use various data analysis tools and techniques to provide accurate and relevant insights.

Contact Us

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: (D) +91 120 433 0800

United States: +1-201-971-6302